1994. The 1994 NIH Report on CRADAs and the Reasonable Pricing Clause
1994. September 8. James Love. Pricing of Drugs Developed with Public Funds. Comments Presented to the Second NIH CRADA Forum.
1995. April 11. NIH Notice Rescinding the Reasonable Pricing Clause, April 11, 1995.
2001. July. NIH Report to Senator Wyden, on NIH and Taxapyer Interests.
2004. July. NIH/OTT Comment on the Affordability of Inventions based upon NIH funding, July 2004.